SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Shane Harrison was appointed as Senior Vice President and Chief Financial Officer of Resideo, effective September 1, 2026, with compensation arrangements including a $550,000 base salary, $2,000,000 initial equity award, and $400,000 sign-on bonus.
View raw filing on EDGAR →BitGo issued a press release on August 12, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing total revenue of $4.3 billion (up 79.6% year-over-year) and a net loss of $19.0 million.
View raw filing on EDGAR →Edward Reginelli, Chief Financial Officer and principal accounting officer, informed the Board on August 10, 2026 of his intention to resign effective September 15, 2026. The Company has launched a formal search for his successor.
View raw filing on EDGAR →Amcor issued a press release on August 12, 2026, disclosing financial results for the fourth quarter and fiscal year ended June 30, 2026. The disclosure includes comprehensive GAAP and adjusted non-GAAP results (net sales, net income, EPS, EBITDA, free cash flow), segment performance, and forward guidance for the transition period. This is a standard earnings release furnished as Exhibit 99.1 under Item 2.02, with material financial metrics showing strong performance (net sales up 57% to $23.5 billion, net income up 116% to $1.1 billion, adjusted EPS up 13% to $4.02).
View raw filing on EDGAR →This exhibit is a press release announcing Jumia's second quarter 2026 financial results, including revenue of $52.0 million (up 14% YoY), gross profit of $30.7 million (up 28% YoY), and narrowed adjusted EBITDA loss of $8.7 million (down 36% YoY). The document also announces a concurrent $50 million capital raise anchored by the International Finance Corporation. As a quarterly earnings announcement with detailed financial metrics and forward guidance reaffirming the path to Q4 2026 breakeven, this is a material earnings release event.
View raw filing on EDGAR →Stem, Inc. issued a press release announcing financial results for Q2 2026 (quarter ended June 30, 2026), disclosing revenue of $33.7M, GAAP gross profit of $13.9M, net loss of $14.4M, adjusted EBITDA of $6.2M, and reaffirming full-year 2026 guidance.
View raw filing on EDGAR →Kontoor Brands issued a press release on August 12, 2026 announcing second quarter fiscal 2026 financial results, including revenue of $584 million (19% increase), adjusted EPS of $1.06 (13% increase), and raised full-year 2026 adjusted EPS guidance to $5.25–$5.35 (27–29% growth). This is a standard quarterly earnings disclosure furnished as Exhibit 99.1 under Item 2.02, materially affecting investor assessment of the registrant's financial performance and outlook.
View raw filing on EDGAR →Joseph A. Alkire is appointed to the role of President and Chief Financial Officer, a material promotion from his prior position as Executive Vice President, CFO and Global Head of Operations. While the disclosure also includes compensatory arrangements (base salary of $900,000, 120% bonus target, and $2.6M long-term incentive award), the principal disclosed action is the appointment to a new executive role. The appointment of a President is material to investors as it signals a significant change in the Company's leadership structure.
View raw filing on EDGAR →This is a standard quarterly earnings release for Grocery Outlet's second quarter fiscal 2026 ended July 4, 2026. The filing discloses net sales of $1.19 billion (up 1.1%), operating income of $15.8 million, and net income of $5.6 million ($0.06 per diluted share), along with comparable store sales trends, gross margin, and forward guidance. The press release is furnished as Exhibit 99.1 and constitutes the primary disclosure under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from the Company's August 7, 2026 annual meeting. The filing presents certified voting outcomes for four proposals: election of three directors, approval of an equity compensation plan amendment, advisory vote on named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditors. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal are the core content of the disclosure.
View raw filing on EDGAR →DeFi Development Corp. issued a press release on August 12, 2026 disclosing Q2 2026 financial results, including revenue of $3.3M (up 67% YoY), net loss of $27.3M, and key operational metrics such as SOL per share growth of 24% year-over-year. The exhibits include the full Q2 2026 Shareholder Letter and Business Update with detailed financial statements, income statement highlights, and forward guidance. This is a standard quarterly earnings disclosure filed under Item 2.02.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 financial results. The Item 2.02 disclosure explicitly states "Enovix Corporation (the 'Company') issued a press release announcing the release of its financial results for the second fiscal quarter 2026," with the press release attached as Exhibit 99.1. The exhibit contains detailed financial results including revenue ($9.0M, up 21% YoY), gross profit, net loss per share, and forward guidance—all hallmarks of a quarterly earnings announcement.
View raw filing on EDGAR →The filing discloses a material delay in the permitting timeline for Greenland Energy's primary exploration project in the Jameson Land Basin. The company announced that the Government of Greenland's review process will be "more extensive, comprehensive" than initially anticipated, pushing the targeted permit timeline from an unspecified earlier date to "winter 2027." This represents a significant operational setback for an exploration-stage company whose core business depends on obtaining drilling permits, and would materially affect investor assessment of project execution risk and capital deployment timing.
View raw filing on EDGAR →Sound Point Meridian Capital entered into a Management Fee Waiver Agreement effective July 1–December 31, 2026, temporarily reducing the adviser's base management fee from 1.75% to 1.50% and narrowing the incentive fee catch-up range.
View raw filing on EDGAR →The Company declared monthly distributions on common stock ($0.13 per share) and preferred stock ($0.16667 and $0.1640625 per share respectively) for the third fiscal quarter 2027.
View raw filing on EDGAR →The filing discloses positive Phase 2a clinical trial results for NEO100 in recurrent IDH1-mutant high-grade glioma, announced via press release on August 12, 2026. The study met its primary endpoint (six-month progression-free survival of 48.9% vs. 20% benchmark, p=0.0047) with favorable secondary outcomes including median overall survival of 26.09 months and no major toxicities. While this is a clinical-stage biotech company rather than a traditional earnings release, the disclosure of material clinical trial results through a press release furnished as Exhibit 99.1 under Item 7.01 (Regulation FD Disclosure) is functionally equivalent to an earnings release—it is a material announcement of significant company results that would affect investor assessment of the registrant's prospects.
View raw filing on EDGAR →OceanLight Acquisition Corporation consummated its initial public offering on August 10, 2026, raising $100 million through the issuance of 10 million units and entering into multiple material definitive agreements including an Underwriting Agreement, Rights Agreement, Warrants Agreement, Investment Management Trust Agreement, and Registration Rights Agreement in connection with the IPO.
View raw filing on EDGAR →OceanLight executed an unregistered private placement of 211,250 units to the Sponsor at $10.00 per unit, generating $2.1125 million in gross proceeds, pursuant to Section 4(a)(2) exemption, concurrent with the IPO.
View raw filing on EDGAR →Effective August 7, 2026, Becky Fallon, Sean Michael Deegan, and Daniel M. McCabe were appointed as members of the board of directors in connection with the effectiveness of the Company's Registration Statement, with specified committee assignments and qualifications as independent directors and audit committee financial expert.
View raw filing on EDGAR →The 8-K discloses quarterly financial results for Q2 2026 (quarter ended June 30, 2026) via Item 2.02 and attached press release (Exhibit 99.1). The filing reports significant deterioration: revenue declined 47.4% YoY to $113.3M, gross margin collapsed from +6.0% to -62.9%, and net loss widened to $84.3M ($1.55 per share) versus $10.3M loss in the prior year quarter. The company explicitly attributes the decline to "unfavorable non-cash adjustments related to legacy disputes" and a $93.6M cumulative catch-up adjustment on claims recoverability. This material earnings disclosure would significantly affect investor assessment of the registrant's financial condition.
View raw filing on EDGAR →This is a classic earnings release disclosure under Item 2.02. Connect Biopharma issued a press release on August 12, 2026 announcing financial results for the three and six months ended June 30, 2026, including cash position ($31.5 million), license and collaboration revenues ($2.8 million and $2.9 million for Q2 and H1 respectively), R&D expenses ($16.3 million and $31.3 million), G&A expenses ($4.1 million and $8.8 million), and net loss ($17.3 million and $36.7 million). The press release also provides material business updates on clinical trial milestones (completion of Phase 2 Seabreeze STAT enrollment) and cash runway expectations. This is material to investors as it discloses the company's financial condition and key operational progress.
View raw filing on EDGAR →AEON Biopharma disclosed its second quarter 2026 financial results on August 12, 2026, reporting a net loss of $12.9 million for the six months ended June 30, 2026, a cash position of $3.4 million, and a $15.3 million financing with milestone warrants.
View raw filing on EDGAR →This is a press release announcing Similarweb's Q2 2026 financial results, including revenue of $77.2 million (9% YoY growth), first-ever quarter of positive GAAP operating profit ($0.7M), and raised full-year guidance. The document contains consolidated financial statements, operational metrics (NRR at 100%, ARR surpassing $300M), and forward-looking guidance for Q3 and FY 2026. This is a classic earnings release disclosing quarterly results and material business developments including strong AI demand and $60M in new contracts.
View raw filing on EDGAR →Direct Digital Holdings issued a press release on August 12, 2026, announcing financial results for Q2 2026 and the six-month period ended June 30, 2026. The disclosure includes detailed revenue, gross profit, operating expenses, net loss, and adjusted EBITDA figures for both periods, along with balance sheet data and management commentary. This is a standard earnings release disclosing quarterly and year-to-date financial results, which is the core purpose of Item 2.02 disclosures.
View raw filing on EDGAR →Pedro Abreu is transitioning from Vice President and Chief Strategy Officer to President, Power Systems, effective September 1, 2026, representing a promotion to a senior operational leadership role. Daniel Griffin is also appointed as President, Aftermarket Solutions. While this involves role changes within the executive team, the principal disclosed action centers on appointments to significant president-level positions overseeing major reportable segments, making exec_appointment the most salient classification.
View raw filing on EDGAR →The exhibit is an investor presentation dated 11 August 2026 disclosing Cadeler's acquisition of Menck, a leading offshore wind foundation equipment provider. The presentation explicitly states "Cadeler has entered into a definitive agreement to acquire 100% of Menck" with an enterprise valuation of EUR 501 million, funded through an EUR 380 million acquisition facility and available liquidity. This is a material acquisition that significantly expands Cadeler's offshore wind installation capabilities and represents a step-change in its foundation transportation and installation offering.
View raw filing on EDGAR →Kelly Youngblood was appointed as Executive Vice President and Chief Financial Officer effective August 12, 2026, replacing Gregory A. Izenstark. The appointment includes a base salary of $680,000, a bonus target of 85%, a long-term incentive target of 225%, and a $2.03 million RSU grant.
View raw filing on EDGAR →This is a press release announcing Marex Group Limited's second quarter 2026 financial results, including revenue of $695.8m (up 39% YoY), Adjusted Profit Before Tax of $165.9m (up 56% YoY), and Basic EPS of $2.09 (up 103% YoY). The document explicitly states "Marex Group Limited announces second quarter 2026 results" and provides comprehensive financial highlights, performance metrics, and management commentary on quarterly and half-year results. This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →This is a press release announcing Logistic Properties of the Americas' second quarter 2026 unaudited consolidated financial results, with total revenue of $14.7 million (up 26.1% YoY) and NOI of $12.2 million (up 27.0% YoY). The document explicitly states it presents "unaudited consolidated financial results for the second quarter ended June 30, 2026" in accordance with IAS 34 Interim Financial Reporting, and includes detailed financial tables, operating metrics, and CEO commentary on quarterly performance. This is a discrete earnings announcement, not a periodic financial report itself.
View raw filing on EDGAR →Alto Neuroscience disclosed financial results for the fiscal quarter ended June 30, 2026 via a press release furnished as Exhibit 99.1. The disclosure includes consolidated statements of operations showing Q2 2026 net loss of $27.6 million (versus $17.7 million in Q2 2025), R&D expenses of $22.1 million, G&A expenses of $7.0 million, and balance sheet data as of June 30, 2026. This is a standard quarterly earnings release with financial statements and operational highlights, meeting the definition of earnings_release under Item 2.02.
View raw filing on EDGAR →AEVEX Corp. issued a press release on August 12, 2026, announcing financial results for the second quarter ended June 30, 2026, disclosing total revenue of $201.8 million (up 99.5% YoY), net income of $6.7 million (versus a net loss of $11.8 million in Q2 2025), and Adjusted EBITDA of $28.1 million. The filing is structured as Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures. The material financial results and forward guidance for full-year 2026 revenue of $700–$720 million and Adjusted EBITDA of $105–$111.5 million would affect a reasonable investor's assessment of the company's performance and prospects.
View raw filing on EDGAR →This is a press release announcing Q2 2026 operating and financial results for Mayfair Gold Corp., explicitly stating "Mayfair Gold Reports Q2 2026 Operating and Financial Results" and directing readers to full financial statements and MD&A. Although the company is development-stage (pre-production), the disclosure of quarterly financial results and operational metrics (project advancement, resource estimates, PFS economics) constitutes a material earnings release that would affect investor assessment of the registrant's progress and financial position.
View raw filing on EDGAR →Smithfield Foods issued a press release on August 11, 2026, announcing second quarter and first-half fiscal 2026 financial results, including net sales of $3.7 billion for Q2 and $7.5 billion for the first half, operating profit of $290 million and $623 million respectively, and diluted earnings per share of $0.60 and $1.23. The filing also includes an updated FY 2026 outlook reflecting macroeconomic headwinds. This is a standard quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →Cardinal Health entered into a new $4.0 billion unsecured revolving credit facility on August 7, 2026, replacing existing credit facilities. The facility includes customary financial covenants and events of default, and will be used for general corporate purposes.
View raw filing on EDGAR →Cardinal Health issued a news release on August 11, 2026, announcing fourth quarter and fiscal year 2026 financial results, including Q4 revenue of $63.7 billion and FY revenue of $254.2 billion, along with GAAP and non-GAAP EPS figures and fiscal year 2027 guidance. The company will host a webcast with the CEO and CFO to discuss the results and outlook.
View raw filing on EDGAR →The filing discloses Middleby Corporation's second quarter 2026 financial results via a press release issued on August 11, 2026. The Item 2.02 section explicitly states "The Middleby Corporation (the 'Company') issued a press release announcing its financial results for the second quarter ended July 4, 2026," with the press release furnished as Exhibit 99.1. The exhibit contains detailed quarterly earnings data including net sales ($875.5M), operating income, adjusted EBITDA, and EPS metrics, along with full-year 2026 guidance, making this a standard earnings release disclosure.
View raw filing on EDGAR →Todd Kelsey was appointed to Littelfuse's Board of Directors effective August 6, 2026, and also appointed to the Compensation Committee. His appointment brings extensive global experience, technology and manufacturing expertise, and public company board experience to the company's governance and strategic direction.
View raw filing on EDGAR →This is a press release announcing Tencent Music Entertainment Group's unaudited financial results for the second quarter ended June 30, 2026. The exhibit discloses total revenues of RMB8.93 billion (5.8% YoY growth), net profit of RMB2.47 billion, and diluted EPS of RMB1.57, along with detailed operational and financial metrics. This is a discrete earnings announcement, not a periodic financial report filing, and would materially affect a reasonable investor's assessment of the company's financial performance and operational trends.
View raw filing on EDGAR →Silicon Laboratories issued a press release on August 11, 2026 announcing its financial results for the fiscal quarter ended July 4, 2026, disclosing revenue of $228 million (up 18% year-over-year), gross margin of 61.6%, and non-GAAP diluted EPS of $0.71 (up 545% year-over-year). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →This 6-K furnishes TSMC's Board resolutions approving the 2026 second quarter Business Report and Financial Statements, along with six-month interim consolidated financial statements (net sales NT$2,404.48 billion, net income NT$1,279.58 billion). The document presents periodic interim financial results for the six-month period ended June 30, 2026, which is the foreign-issuer equivalent of a 10-Q interim report. While the filing also discloses a dividend distribution and capital appropriations, the primary substance is the interim financial report itself.
View raw filing on EDGAR →The disclosure announces a repeat order for ROAMEO autonomous security patrol vehicles from a major enterprise logistics client, representing continued commercial traction and customer expansion. While this is a business development milestone rather than a specific named event type, it is clearly operational in nature—involving a product order, customer relationship expansion, and deployment timeline. The materiality is supported by the company's emphasis on this as a "repeat order" from a "long-standing client" that "has deployed dozens of RAD solutions," indicating significant revenue and strategic importance to the company's core business.
View raw filing on EDGAR →This exhibit is a notice announcing that Americas Gold and Silver Corporation will release its second quarter 2026 financial results on August 14, 2026, and will host a conference call to discuss those results. The document explicitly states "Americas plans to issue a news release containing second quarter 2026 results before markets open in North America on Friday, August 14, 2026." This is a disclosure of periodic quarterly financial results, which constitutes an earnings release event material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →Peabody Energy disclosed an investor site tour and presentation at its Centurion Mine on August 11, 2026, with detailed operational and financial updates on the mine's ramp-up to full longwall production, market positioning, and economics. While Item 7.01 (Regulation FD Disclosure) is typically used for routine investor communications, the substance here—production targets, operational challenges (shield racking), cost structure, and $2.1 billion NPV valuation of a cornerstone asset—constitutes material operational and strategic information about a major business initiative that would affect a reasonable investor's assessment of the company's prospects and capital allocation.
View raw filing on EDGAR →Sony Semiconductor Solutions and TSMC have signed a definitive agreement to establish a joint venture ("Advanced Vision Semiconductor Manufacturing Corporation") for next-generation image sensor development and manufacturing. Sony will contribute approximately 465 billion yen and be the sole controlling shareholder with consolidated subsidiary status, while TSMC contributes approximately 282 billion yen. This represents a material strategic partnership and capital commitment that would affect a reasonable investor's assessment of Sony's business strategy and financial position.
View raw filing on EDGAR →This is a press release announcing IHS Holding Limited's second quarter 2026 financial results, including revenue of $428.6 million from continuing operations (up 10.4% YoY), Adjusted EBITDA of $245.3 million, and ALFCF of $57.1 million. The document explicitly states "FOR IMMEDIATE RELEASE" and "IHS HOLDING LIMITED REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS" with detailed financial metrics, segment performance, and operational highlights. This is a classic earnings release disclosing quarterly financial results.
View raw filing on EDGAR →This is an amendment letter to a US$200,000,000 term credit facility agreement dated 19 June 2025. The amendment modifies the Margin definition, changing the interest rate structure from a single 4.85% margin to a tiered schedule ranging from 3.85% to 5.85% depending on the period. While technically an amendment to existing debt rather than a new issuance, it materially alters the financial terms of a direct financial obligation and would affect a reasonable investor's assessment of the company's cost of capital and debt burden.
View raw filing on EDGAR →BioXcel entered into the Twelfth Amendment to its Credit Agreement on August 10, 2026, modifying existing debt terms. While this is technically an amendment to an existing credit facility rather than issuance of new debt, the filing is disclosed under Item 1.01 (Material Definitive Agreement). However, the substance here is a covenant modification and extension of a deadline to refinance or execute an alternative capital transaction—signaling financial stress and potential covenant breach risk rather than new debt creation. The requirement to refinance by August 21, 2026, and the reduction of minimum liquidity from $6.25M to $3.0M suggest the company is under pressure to restructure its capital.
View raw filing on EDGAR →DPC Holdings PLC issued a press release on August 11, 2026 disclosing financial results for the second quarter ended June 28, 2026. The release reports record revenue of $269 million (up 34% YoY), adjusted EBITDA of $48 million (up 33% YoY), and provides full-year 2026 guidance of $1,000m–$1,040m revenue and $182m–$187m adjusted EBITDA. This is a standard quarterly earnings disclosure attached as an exhibit to Item 2.02, meeting the definition of earnings_release.
View raw filing on EDGAR →908 Devices announced preliminary financial results for Q2 2026 and fiscal year 2026 via press release furnished as Exhibit 99.1. The disclosure includes detailed quarterly and six-month financial statements (revenue of $16.1M, net loss from continuing operations of $11.9M), updated full-year 2026 revenue guidance (raised to $68.0M–$70.0M), and key operational metrics. This is a standard earnings release under Item 2.02.
View raw filing on EDGAR →Robert John, Chief Revenue Officer, terminated employment effective immediately on August 10, 2026, under circumstances entitling him to severance pay and benefits. The press release confirms his departure and announces Paul Verrastro as interim replacement, citing "revised commercial outlook and need to improve commercial execution" as the reason for the leadership change. This is a material departure of a named executive officer responsible for revenue generation at a commercial-stage medical device company.
View raw filing on EDGAR →